Implementation and Audit of Mainstream Genetic Testing Within a High‐Volume UK Breast Unit for Pathogenic Variations Associated With Breast Cancer Using the R208 and R444.1 National Test Directory Criterion.

Introduction: It is estimated that 5%–10% of patients who develop breast cancer have a causative inherited pathogenic or likely pathogenic variant (P/LP variant). In 2020, the UK National Test Directory published criteria for mainstream genetic testing for breast cancer patients (R208) and, subseque...

Descripción completa

Detalles Bibliográficos

Publicado en:	Breast Journal Vol. 2026; pp. 1 - 15
Autores principales:	Conroy, Soraya, Keane, Emma, Rehman, Bushra, Wyborn, Eleanor, Brown, Catherine, Chen, Lamb, Chatten, Josh, Durston-Rand, Elijah, Sheehan, Blaise, Ferguson, Elizabeth, Miles, Tracie, Beck, Emma, Hunter-Smith, Alison, Laban, Christiana, Smith, Katherine, Dalgliesh, Diana, Bowen, Rebecca, Laurence, Nicola, Wani, Imtiaz
Formato:	pictorial research tables/charts Journal Article
Publicado:	Wiley-Blackwell 7/27/2026
Acceso en línea:	Ver este registro en EBSCOhost